PPD Accelerating Delivery Via Site Intelligence And Activation

As drug development moves through a period of significant innovation and complexity, our industry is faced with longer development timelines, increased cost pressures, greater regulatory challenges and the need for expanded global harmonization and planning across development functions.

Evaluating our performance over the past four years, PPD has met industry benchmarks for key site activation and enrollment measures across all Phase II-IV trials. A closer examination of data reveals the following examples of our consistently strong performance.